By navigating the complex regulatory environment from a global perceptive, the company has developed a full spectrum of cost-effective yet innovative products and services that emphasize more on quality. With its rigorously tested and easily implementable services and products, arivis AG’s mission is to be a solution provider that expedites the process.
As a biomedical big image data and compliance software provider for the life sciences industry, the company has designed its innovative imaging technology, which arms researchers with the ability to understand, assess, modify, and test new theories. It also allows for the analysis of data using immersive technology (4D imaging), which is pivotal to research centers across the world. With its customer-centric compliance software that is intuitive, stable, and easy to implement, the company today serves customers in over 25 countries.
With its rigorously tested and easily implementable services and products, arivis AG’s mission is to be a solution provider that expedites the process
In one instance, a client of arivis AG was facing a challenge to migrate thousands of documents from three clinical trials onto arivis AG’s platform. Backed by an expert team of engineers and subject matter experts, the company helped its client to migrate seamlessly by receiving the documents and placing them into the workflow stream immediately. Also, all users of the system were able to carry on their tasks without any impediments.
To stay abreast of the trends the company utilizes feedback given by its customers, industry trends, and the regulatory dynamics to create innovative products for life science customers to make the workflow process efficient and more productive.
In another instance, one of its CRO clients approached arivis AG as they were not able to manage clinical trial documents and access the documents in a timely fashion. Simultaneously, documents were checked out by multiple users, and all artifacts were not being utilized. Aforementioned led to a situation of uncertainty where the client could not proceed any further as the audit trial was not reliable and caused a delay in the event of the audit. By proffering an out-of-the-box compliant solution which included index mapping and user training, the company helped the client to manage communications between all parties and substantially reduced audit risk.
Throughout its journey in this space, the company has been innovating with its solutions abiding by the input from its clients. The coming years will be no different. Going forward, the company intends to develop cutting-edge solutions for its clients across life sciences with a specific focus in the e-clinical and regulatory compliance space.